Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MFA Financial Inc MFA.PR.C


Primary Symbol: MFA Alternate Symbol(s):  MFA.PR.B

MFA Financial, Inc. is an internally managed real estate investment trust that invests in and finances residential mortgage assets. The Company’s targeted investments include principally residential whole loans and residential mortgage securities. Its residential whole loans include purchased performing loans, purchased credit deteriorated and purchased non-performing loans. Its residential mortgage securities include agency mortgage-backed securities (MBS), non-agency MBS, credit risk transfer securities, and MSR-related assets, which include term notes backed directly or indirectly by mortgage servicing rights (MSRs). Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The Company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return.


NYSE:MFA - Post by User

Post by GenevaCon Apr 16, 2022 11:35am
139 Views
Post# 34607501

FSD Pharma Inc: Lucid MS Video

FSD Pharma Inc: Lucid MS Video


FSD Pharma is delighted to announce pre-clinical findings indicating the efficacy of Lucid-MS, its flagship medication candidate, in treating Multiple Sclerosis. Lucid-MS's therapeutic potential is an industry first, and we'd like to provide visual evidence of functional recovery in pre-clinical individuals in this video!

<< Previous
Bullboard Posts
Next >>